Olga Rivero-Menéndez

In vitro activity of olorofim (F901318) against clinical isolates of cryptic species of Aspergillus by EUCAST and CLSI methodologies

Olga Rivero-Menéndez, Manuel Cuenca‐Estrella, Ana Alastruey‐Izquierdo · Journal of Antimicrobial Chemotherapy · 2019 · 68 citations

Life Sciences, Infectious Diseases, Microbiology +17

Genomic and Phenotypic Heterogeneity of Clinical Isolates of the Human Pathogens Aspergillus fumigatus, Aspergillus lentulus, and Aspergillus fumigatiaffinis

Renato Santos, Jacob L. Steenwyk, Olga Rivero-Menéndez et al. · Frontiers in Genetics · 2020 · 67 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Rapid Development of Candida krusei Echinocandin Resistance during Caspofungin Therapy

Agustina Forastiero, V. Garcia-Gil, Olga Rivero-Menéndez et al. · Antimicrobial Agents and Chemotherapy · 2015 · 65 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study)

Ana Alastruey‐Izquierdo, Laura Alcázar‐Fuoli, Olga Rivero-Menéndez et al. · Antimicrobial Agents and Chemotherapy · 2018 · 53 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

In vitro activity of APX001A against rare moulds using EUCAST and CLSI methodologies

Olga Rivero-Menéndez, Manuel Cuenca‐Estrella, Ana Alastruey‐Izquierdo · Journal of Antimicrobial Chemotherapy · 2019 · 50 citations

Life Sciences, Biology, Microbiology +17